Steel Peak Wealth Management LLC Crispr Therapeutics Ag Transaction History
Steel Peak Wealth Management LLC
- $2.12 Billion
- Q2 2024
A detailed history of Steel Peak Wealth Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Steel Peak Wealth Management LLC holds 15,660 shares of CRSP stock, worth $735,863. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,660
Previous 10,253
52.74%
Holding current value
$735,863
Previous $698,000
21.06%
% of portfolio
0.04%
Previous 0.04%
Shares
14 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$370 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$366 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$148 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$148 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$131 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.67B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....